Literature DB >> 24840556

Does left atrial enlargement contribute to mitral leaflet tethering in patients with functional mitral regurgitation? Proposed role of atriogenic leaflet tethering.

Jeffrey J Silbiger1.   

Abstract

Papillary muscle repositioning due to left ventricular remodeling is thought to be the primary mechanism responsible for functional mitral regurgitation. This article proposes that remodeling (enlargement) of the left atrium also plays a role in the pathogenesis of functional mitral regurgitation, through a novel mechanism-atriogenic leaflet tethering-described herein.
© 2014, Wiley Periodicals, Inc.

Entities:  

Keywords:  functional mitral regurgitation; left atrium; left ventricular remodeling; mitral valve

Mesh:

Year:  2014        PMID: 24840556     DOI: 10.1111/echo.12629

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

1.  Pathoanatomy of Mitral Regurgitation.

Authors:  Ilya Karagodin; Amita Singh; Roberto M Lang
Journal:  Struct Heart       Date:  2020-06-12

2.  Relation of Mitral Annulus and Left Atrial Dysfunction to the Severity of Functional Mitral Regurgitation in Patients with Dilated Cardiomyopathy.

Authors:  Sorina Mihaila Baldea; Denisa Muraru; Marcelo Haertel Miglioranza; Sabino Iliceto; Dragos Vinereanu; Luigi Paolo Badano
Journal:  Cardiol Res Pract       Date:  2020-07-09       Impact factor: 1.866

Review 3.  Fill in the Gaps of Secondary Mitral Regurgitation: a Continuum Challenge From Pathophysiology to Prognosis.

Authors:  Riccardo M Inciardi; Andrea Rossi; Giovanni Benfari; Mariantonietta Cicoira
Journal:  Curr Heart Fail Rep       Date:  2018-04

4.  Reduced longitudinal contraction is associated with ischemic mitral regurgitation after posterior MI.

Authors:  Kiyotake Ishikawa; Shin Watanabe; Nadjib Hammoudi; Jaume Aguero; Olympia Bikou; Kenneth Fish; Roger J Hajjar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-03       Impact factor: 4.733

5.  Decreased Mortality with Beta-Blocker Therapy in HFpEF Patients Associated with Atrial Fibrillation.

Authors:  Yanhua Yang; Suxia Guo; Ziyao Huang; Chunhua Deng; Lihua Chen; Guoxiang Zhou; Zhengwei Jian; Ruping He; Zhichao Huang; Yongzhao Yao; Jiongbin Lu; Zhiwen Hua; Yuli Huang
Journal:  Cardiol Res Pract       Date:  2020-05-13       Impact factor: 1.866

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.